Related Experiment Videos
Biliary atresia: outcome and management
1Department of Pediatric Surgery, King's College Hospital, London SE5 9RS, United Kingdom. Markdav2@ntlworld.com
Insights
Biliary atresia (BA) is a fatal newborn condition. Early Kasai portoenterostomy surgery can restore bile flow, clear jaundice in 50% of infants, and improve long-term outcomes.
Area of Science:
- Pediatric Surgery
- Neonatal Hepatology
Background:
- Biliary atresia (BA) is a critical neonatal liver disease leading to liver failure if untreated.
- Early diagnosis and intervention are crucial for improving infant outcomes.
Purpose of the Study:
- To evaluate the efficacy of Kasai portoenterostomy in treating biliary atresia.
- To assess the impact of surgical timing on jaundice clearance and long-term survival.
Main Methods:
- Review of the Kasai portoenterostomy procedure for biliary atresia.
- Analysis of surgical outcomes, including jaundice clearance and long-term survival rates.
Main Results:
- Approximately 50% of infants achieve jaundice clearance after Kasai portoenterostomy.
- Successful surgery, performed before cirrhosis, offers a good quality of life and survival into adulthood.
- Liver transplantation remains an option for non-responders, but faces challenges like organ shortage.
Conclusions:
- Kasai portoenterostomy is a vital surgical intervention for biliary atresia.
- Timely surgical management significantly improves prognosis and long-term outcomes for affected infants.
Abstract:
Untreated, biliary atresia remains a fatal condition of the newborn. Most present within four to six weeks of conjugated jaundice and acholic stools and, although still a challenging diagnosis to make, therein lies the opportunity of changing the course of this otherwise inexorable disease. The aim of surgery is to restore bile flow, alleviate jaundice and abbreviate the cholangiodestructive process within the liver. The Kasai portoenterostomy, introduced almost 50 years ago in Japan, aims to expose microscopic biliary ductules within the fibroinflammatory mass at the porta hepatis and restore bile drainage into a mobilised Roux loop. About 50% of infants with BA will be able to clear their jaundice following Kasai alone, given appropriately experienced surgeons and if performed prior to the onset of overt cirrhosis. They have a reasonable expectation of long-term survival to adulthood with a good quality-of-life. The remainder may be candidates for liver transplantation (where available) although donor organ shortage and immunosuppresion-related complications remain significant problems.
